A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis
Clinical trial NCT07158151 · COMPLETED
Trial details
- NCT number
- NCT07158151
- Sponsor
- Reistone Biopharma Company Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-25
- Primary completion
- 2026-04-10
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.